2768 results found
NHMRC is the Australian Government’s primary health and medical research funding agency. With NHMRC support, Australia undertakes outstanding health and medical research which has contributed to significant improvements in individual and population health.
The safety and health effects of electronic cigarettes (e-cigarettes) are contested. Public health officials have expressed concern at the growing uptake of e-cigarettes, particularly amongst young people. NHMRC has reviewed the current evidence to provide public health advice on the safety and impacts of e-cigarettes.
The following resources may help you to find out more about e-cigarettes. Evidence reviews used to inform the CEO Statement on Electronic Cigarettes can be downloaded from the CEO Statement tab.
The advice and resources on this page have been provided for public information and to assist the water sector in responding to emerging water issues in the absence of official NHMRC advice.
NHMRC has developed a suite of resources to assist developers in following the NHMRC guideline approval process and meeting the requirements.
The Procedures and requirements for meeting NHMRC standards for clinical practice guidelines are designed to support guideline developers, including those seeking NHMRC approval, to ensure guidelines are developed to the highest standard.
As Australia’s leading experts on health and medical research, NHMRC develops evidence based advice on priority health topics to prevent disease, improve health and help the states and territories to achieve consistent standards.
We are committed to improving the health of Aboriginal and Torres Strait Islander peoples.
Road Map 3 is a comprehensive 10-year strategic framework to improve the health of Australia's Aboriginal and Torres Strait Islander population.
Information about the functions and composition of previous NHMRC Committees and Advisory Groups.
NHMRC is committed to building and strengthening the capacity and capability amongst Aboriginal and Torres Strait Islander health researchers. We do this through funding, events and educational opportunities. Read about some of the capacity and capability initiatives we are involved with.
Purpose The purpose of this statement is to clarify the expectations of the National Health and Medical Research Council (NHMRC) with respect to the use of smoke inhalation procedures in rodents in NHMRC-funded research. It can also be used by those involved with, or considering, the use of smoke inhalation procedures in rodents in research funded from other sources.
This data glossary provides definitions for key terms frequently used by NHMRC to describe our data. The data dictionary (available to download below) defines and describes key fields within our systems. These serve as a reference guide to ensure consistency and clarity in understanding terms we use.
This data dictionary provides definitions for key terms frequently used by NHMRC to describe our data. It serves as a reference guide to ensure consistency and clarity in understanding terms we use.
The NHMRC score descriptor working group (the working group) is providing advice to NHMRC on improving the score descriptors and the research impact criteria for the Investigator and Synergy Grant schemes, for implementation from the 2025 and 2026 Investigator Grant funding rounds.
The objective of the CTCS Grant scheme is to support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health.
The objective of the CTCS Grant scheme is to support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health.
As a recommended action under NHMRC’s Road Map 3: A strategic framework for improving Aboriginal and Torres Strait Islander health through research and associated Action Plan 2021–2024 Triennium, a review of the Indigenous Research Excellence Criteria (IREC) was undertaken in 2023. This included national consultation with the feedback considered by the Principal Committee Indigenous Caucus (PCIC) and a consultation report released in December 2023.